Thyroid hormone responsive protein (Thrsp, also known as Spot 14 and S14) is a carbohydrate-inducible and thyroid-hormone-inducible nuclear protein specific to liver, adipose and lactating mammary tissues. Thrsp functions to activate genes encoding fatty-acid synthesis enzymes. Recent studies have shown that in some cancers human Thrsp (hS14) localizes to the nucleus and is amplified, suggesting that it plays a role in the regulation of lipogenic enzymes during tumourigenesis. Thrsp, a member of the Spot 14 superfamily, is an acidic homodimeric protein with no sequence similarity to other mammalian gene products and its biochemical function is elusive. To shed light on the structure-function relationship of this protein, human Thrsp was crystallized. Recombinant human Thrsp (hThrsp), the N-terminally truncated human Thrsp 10-146 (hThrsp9) and their selenomethionyl (SeMet) derivatives were expressed in Escherichia coli, purified and crystallized using the hanging-drop vapour-diffusion method. Diffraction-quality crystals were grown at 293 K using Li 2 SO 4 as a precipitant. Using synchrotron radiation, data for the hThrsp SeMet derivative, hThrsp9 and its SeMet derivative were collected to 4.0, 3.0 and 3.6 Å resolution, respectively, at 100 K. The crystals of full-length hThrsp and its SeMet derivative belonged to space group P4 1 2 1 2, with approximate unit-cell parameters a = b = 123.9, c = 242.1 Å , = = = 90.0
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Introduction
The thyroid hormone responsive protein (Thrsp, also known as Spot 14 and S14) is an $17 kDa acidic (pI 4.65) protein bearing no sequence similarity to other functional motifs and with a strong propensity for homodimerization (Cunningham et al., 1997; Chou et al., 2007) . It was first identified in 1982 as a result of its marked and rapid induction by thyroid hormone (Seelig et al., 1982) . The multilayered regulation and nuclear localization of Thrsp led researchers to believe that it plays a role in tissue-specific control of metabolism in response to changing dietary and hormonal factors (Campbell et al., 2003; Cunningham et al., 1998; Franklyn et al., 1989) . Thrsp has been reported to be a homodimeric transcriptional activator that serves as a component of a tripartite complex with a 36 kDa hepatic protein in rat liver to modulate gene expression (Cunningham et al., 1997) . The biochemical mechanism of Thrsp is not known, but it evidently functions to transduce hormone-and nutrient-related signals to genes involved in lipid metabolism. Expression of the human Thrsp (hThrsp, hS14) gene is abundant in those tissues that are active in long-chain fatty-acid synthesis, such as the lactating mammary gland (Dozin et al., 1986; Kinlaw et al., 1995; Ma & Goodridge, 1992) , and its localization in hepatic nuclei further suggests that it functions in the regulation of lipogenic enzyme genes (Brown et al., 1997; Cunningham et al., 1998; Kinlaw et al., 1992; Zhu et al., 2001 Zhu et al., , 2005 . Furthermore, hThrsp in the cancer amplicon has been proposed as a biomarker of aggressive breast cancer Moncur et al., 1997; Taviaux et al., 1997) , promoting a lipogenic tumour phenotype characterized by high fatty-acid synthesis rates, elevated lipogenic enzyme levels in tumours (e.g. fatty-acid synthase, acetyl-CoA carboxylase and malic enzyme) and a dependence on lipogenesis for tumour-cell growth (Towle et al., 1997; Kuhajda, 2000) . In MCF-7 human breast-cancer cells, overexpression of hS14 decreases cell growth and induces cell death and differentiation (Sanchez-Rodriguez et al., 2005) . A recent study demonstrated that hThrsp physically and functionally interacts with the thyroid receptor (TR) in the regulation of malic enzyme gene expression. The ubiquitous expression of hThrsp in various cell lines and its cell-type-dependent functions suggest that it acts as a positive or negative cofactor of the TR to regulate malic enzyme gene expression (Chou et al., 2007) . Similarly, its nuclear localization also suggests that hThrsp might act as a transcription cofactor in the regulation of specific genes. Chou and coworkers showed that its C-terminal region regulates the potential transactivation activity of hThrsp and is involved in the regulation of p53-dependent transactivation. hThrsp might therefore regulate the transcription and translation of p21, the p53 target gene, via direct interaction with the TR or other p53 coactivators such as Zac1 (zincfinger protein which regulates apoptosis and cell-cycle arrest 1; Chou et al., 2008) . These studies suggest a molecular basis for a novel function of human Thrsp in TR-dependent or p53-dependent transcriptional activation of specific gene expression.
At the end of 2010, Colbert and coworkers reported the monomer structure of murine S14 and indicated the structure of the homodimer via crystallographic symmetry. Based on the structure of S14, they suggested a mechanism in which heterodimer formation with MIG12 attenuates the ability of MIG12 to activate ACC (Colbert et al., 2010) . Comparison of the amino-acid sequences of human Thrsp and mouse S14 revealed 82% identity ( Fig. 1 ) and indicated certain differences in three antiparallel -helices and one region (residues 77-104 of mouse S14, corresponding to 77-101 of hThrsp) that was not modelled in the structure of mouse S14. These regions may give rise to different physiological consequences for human Thrsp and mouse S14, such as the recognition of different partners. As human Thrsp is a driver and a marker of virulent breast cancer and a potential therapeutic target Wells et al., 2006) , the precise structure of hThrsp will help to elucidate its precise biological mechanism and benefit the discovery of novel anticancer drugs. Therefore, in order to explore the detailed function of hThrsp, we set out to determine its threedimensional structure. Here, we report our results on the expression, purification, crystallization and preliminary X-ray crystallographic analysis of recombinant hThrsp, the N-terminally truncated hThrsp9 and their respective SeMet derivatives.
Materials and methods
Gene cloning
A full-length cDNA fragment (Thrsp gene) encoding hThrsp was cloned into the expression plasmid pGEX-6P-1 vector (GE Healthcare) between the EcoRI and XhoI restriction sites. Thrsp and GST are connected by a short linker sequence containing a PreScission protease cleavage site, which after cleavage yields recombinant hThrsp with eight additional residues (GPLGSPEF) at its N-terminus (17.35 kDa and 154 amino-acid residues in total).
Oligonucleotide primers were designed to amplify the nucleotide sequence corresponding to a construct in which the nine N-terminal amino acids were deleted (hThrsp9) by polymerase chain reaction (PCR) using the above construct as a template. The primer sequences, which contained BamHI and XhoI restriction sites (shown in bold), were th-9F, 5
0 -CGGGATCCAAGAACTGCCTGCTGACC-3 0 , and th-9R, 5
0 -CCGCTCGAGCTACCAAACTTGTCC-3 0 . The PCR product was cloned into the expression vector pGEX-6P-1 by conventional cloning methods. The recombinant hThrsp9 has an additional five residues (GPLGS) at its N-terminus (15.85 kDa and 142 amino-acid residues in total) after cleavage. The constructed plasmids were verified by DNA sequencing.
Expression and purification
Each recombinant plasmid was transformed into Escherichia coli strain BL21 (DE3) and transformed cells were plated onto LB plates containing 100 mg ml À1 ampicillin. A single colony was picked and grown overnight at 310 K in 10 ml LB medium containing 100 mg ml À1 ampicillin. The following day, 10 ml of the overnight culture was added to 1 l LB medium containing 100 mg ml À1 ampicillin. When the culture density reached an A 600 of 0.6-0.8, induction with 1 mM IPTG (isopropyl -d-1-thiogalactopyranoside) was performed and cell growth continued for 24 h at 289 K.
After harvesting by centrifugation (4000 rev min
À1
, 30 min, 277 K), cells were resuspended in PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 Á12H 2 O, 1.8 mM KH 2 PO 4 pH 7.4) and then Sequence alignment between human Thrsp (hThrsp; NP_003242.1) and mouse Spot 14 (mS14; NP_033407.1). The numbering above the alignment corresponds to the hThrsp sequence. Secondary-structure elements for the mouse Spot 14 structure are labelled. sonicated. After centrifugation at 18 000 rev min À1 for 30 min at 277 K, the clarified supernatant was passed through a glutathioneSepharose 4B column (equilibrated with PBS buffer). The GSTfusion protein-bound column was washed with ten column volumes of PBS buffer. The GST-fusion proteins were cleaved by PreScission protease overnight at 277 K in cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM DTT, 1 mM EDTA pH 8.0). The target protein (hThrsp or hThrsp9) was then eluted with buffer A (25 mM Tris-HCl, 150 mM NaCl pH 8.0) and loaded onto a Mono Q (GE Healthcare) ion-exchange chromatography column run in buffer A. After washing away the unbound protein with two bed volumes, a linear gradient of 0.15-1 M NaCl in the same buffer was applied. The target protein was further purified by gel filtration on a Superdex 75 HR 10/30 (GE Healthcare) column run in 25 mM Tris-HCl pH 8.0, 150 mM NaCl (see Fig. 2a ). The elution profile of hThrsp9 was very similar to that of hThrsp on a Superdex 75 HR 10/30 column. The purity of the proteins was then analyzed on SDS-PAGE (better than 95% purity) and was judged to be suitable for crystallization (see Fig. 2b ).
SeMet-labelled (SeMet) hThrsp was also expressed in E. coli strain BL21 (DE3). After overnight incubation in LB medium containing 100 mg ml À1 ampicillin, the cells were diluted with adaptive medium (20% LB medium, 80% M9 medium) and grown at 310 K to an OD 600 of 0.6-0.8. The cells were harvested and resuspended in M9 medium, transferred into restrictive medium [5%(w/v) glucose] and grown to an OD 600 of 0.6-0.8 before induction. SeMet at 60 mg l À1 , lysine, threonine and phenylalanine at 100 mg l À1 , leucine, isoleucine and valine at 50 mg l À1 and 1 mM IPTG were added and incubation was continued at 289 K for about 24 h. The cells were harvested and SeMet hThrsp was purified and crystallized using the same method as used for the native protein, except for the addition of a reducing environment provided by 5 mM DTT and 0.5 mM EDTA. The expression and purification and crystallization of SeMet hThrsp9 were similar to those of SeMet hThrsp. Incorporation of selenium was confirmed by mass-spectrometric analysis.
Crystallization
Purified hThrsp was exchanged into crystallization buffer (25 mM Tris-HCl pH 8.0, 50 mM NaCl) and concentrated to 20-30 mg ml À1 using a 5K ultrafiltration tube (Millipore). Crystallization experiments were performed at 293 K using the hanging-drop vapourdiffusion method. Preliminary crystallization trials were carried out manually using commercially available sparse-matrix screens including Crystal Screen, Index and SaltRx kits from Hampton Research, Wizard kits I and II from Emerald BioSystems and AmSO4, MPDs and Nucleix from Qiagen. Each drop was formed by mixing 1 ml protein solution and 1 ml reservoir solution and was allowed to equilibrate via vapour diffusion over 200 ml reservoir solution. Crystals of recombinant hThrsp were obtained using several conditions. After optimization, the best crystals were obtained from 0.95-1.05 M Li 2 SO 4 , 0.05 M sodium cacodylate trihydrate pH 6.0, 0.02 M MgCl 2 . Crystals (0.2 Â 0.2 Â 0.3 mm in size; Fig. 3) were obtained in about one week. The purified SeMet derivative was concentrated to 15-30 mg ml À1 . Crystallization trials were set up based on the optimum conditions used for the native protein.
After gel filtration, purified hThrsp9 was concentrated to 20-30 mg ml À1 using a 5K ultrafiltration tube. The best crystals of hThrsp9 were obtained from a similar crystallization condition to that observed for hThrsp: 0.95-1.0 M Li 2 SO 4 , 0.1 M MES pH 5.0, 0.02 M MgCl 2 , 0.1 M KCl. Crystals (0.15 Â 0.15 Â 0.25 mm in size; Fig. 3 ) appeared in 2-3 weeks and grew to their full size within 1-2 months. Meanwhile, purified SeMet hThrsp9 was concentrated to 5-10 mg ml À1 and crystallized based on the optimum conditions for the hThrsp9 crystals.
Data collection and processing
The diffraction quality of native hThrsp crystals was similar to that of its SeMet-derivative crystals. Data were collected from a single SeMet hThrsp crystal at the peak ( 1 ; 0.97984 Å ) wavelength to 4 Å resolution on beamline BL-17A under cryoconditions at the Photon Factory (Tsukuba, Japan). Data were also collected from a single SeMet hThrsp9 crystal at the peak ( 1 ; 0.97900 Å ) wavelength to 3.6 Å resolution on beamline BL-5A of the Photon Factory using an ADSC Quantum 315 CCD detector. Native data were also collected from an hThrsp9 crystal to 3.0 Å resolution on beamline BL17U of the Shanghai Synchrotron Radiation Facility (SSRF, China). Fig. 4 shows a typical diffraction pattern of SeMet hThrsp or hThrsp9 crystals.
During data collection, the crystals were flash-cooled to 100 K using a Cryostream (Oxford Cryosystems) in a cryoprotectant that was prepared by adding 20% glycerol to the mother liquor. Data processing and scaling were performed with the HKL-2000 package (Otwinowski & Minor, 1997) . Data-collection statistics are reported in Table 1 .
Results and discussion
Based on the results of size-exclusion chromatography using a Superdex 75 HR 10/30 column (see Fig. 2 ) and related reports (Cunningham et al., 1997; Chou et al., 2007; Colbert et al., 2010) , both hThrsp9 and hThrsp exist as homodimers in solution. At the time, no similar structures to hThrsp were available in the Protein Data Bank (PDB). As the sequence of hThrsp included six methionines, we Table 1 Data-collection and processing statistics. 4.00 (4.14-4.00) 3.00 (3.05-3.00) 3.60 (3. therefore opted to construct a SeMet-derivative protein to facilitate structure determination by the multiple/single-wavelength anomalous dispersion (MAD/SAD) method. In order to optimize the crystallization conditions for hThrsp and its SeMet-derivative crystals following our initial screen, we varied a number of parameters, including the precipitant, buffer pH, salt, protein concentration and temperature and the use of additives, detergents and seeding. However, the diffraction resolution was not markedly improved. Finally, data to 4 Å resolution were collected from a SeMet hThrsp crystal using synchrotron radiation. The unitcell parameters were determined to be a = b = 123.9, c = 242.1 Å , = = = 90.0 in space group P4 1 2 1 2 or P4 3 2 1 2. Data-collection statistics from a SeMet-derivative crystal are shown in Table 1 . Based on the Matthews coefficient (Matthews, 1968) , we estimated there to be 12 molecules in the asymmetric unit, with a Matthews coefficient (V M ) of 2.33 Å 3 Da À1 and an estimated solvent content of 47%. In order to solve the structure and thus elucidate the precise mechanism of human Thrsp, we truncated the nine N-terminal amino acids to form a new protein construct (hThrsp9) based on the results of secondary-structure prediction using the ExPASy proteomics server (http://expasy.org). It was anticipated that truncating the disordered N-terminal fragment of hThrsp would result in more compact or regular packing within the crystals. The hThrsp9 construct was thus expressed, purified and crystallized, together with its SeMet derivative, following the same protocol as used for the full-length hThrsp. As a result, native data from the hThrsp9 crystal and peakwavelength data from the SeMet hThrsp9 crystal were collected using synchrotron radiation. Data sets were indexed and processed with Table 1 .
While we were in the process of further optimizing the crystals and determining the structure by MAD/SAD phasing, the crystal structure of another member of the Spot 14 family, mouse S14 (PDB entry 3ont), was determined and reported by Colbert et al. (2010) . Mouse S14 was crystallized in space group I432 with a single monomer in the asymmetric unit and a homodimer was inferred from crystallographic symmetry. Given that the amino-acid sequence identity between hThrsp and mouse S14 is 82%, we therefore attempted to determine the crystal structure of hThrsp9 by the molecular-replacement method using the structure of the mouse S14 monomer as a search model. A molecular-replacement solution was found in Phaser with six molecules per asymmetric unit comprising three homodimers and corresponding to a Matthews coefficient V M of 4.70 Å 3 Da À1 and a solvent content of 74%. An analysis of the molecular-replacement solution showed loose packing of the hThrsp9 molecules (Fig. 5) . This solution is consistent with the self-rotation function calculated using MOLREP, which shows threefold ( = 120 ) and twofold ( = 180 ) axes but no substantial peaks in the = 60 section indicative of sixfold symmetry (data not shown). After initial refinement of the molecular-replacement solution, the working and free R factors were reduced from 49.3% and 48.3% to 33.2% and 38.5%, respectively.
The unexpected high solvent content of 74% should help to account for the consistently poor diffraction of hThrsp and hThrsp9 crystals. Although rare, there have been cases in which a structure has been determined from crystals with unusually high solvent content.
For example, the diffraction by tetragonal crystals of human serum albumin only reaches a maximum resolution of 3.0 Å owing to their high solvent content of 77% and loose packing in the crystal lattice (Sugio et al., 1999) . Further refinement of the hThrsp9 structure is under way and will be reported elsewhere.
